Search Results - "Peeters, Silke"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Ultrathin superconducting TaCxN1−x films prepared by plasma-enhanced atomic layer deposition with ion-energy control by Peeters, Silke A., Lennon, Ciaran T., Merkx, Marc J. M., Hadfield, Robert H., Kessels, W. M. M. (Erwin), Verheijen, Marcel A., Knoops, Harm C. M.

    Published in Applied physics letters (25-09-2023)
    “…This work demonstrates that plasma-enhanced atomic layer deposition (PEALD) with substrate biasing enables the preparation of ultrathin superconducting…”
    Get full text
    Journal Article
  2. 2

    Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant by Peeters, Silke, Fedoryshchenko, Ivanna, Rabaut, Laura, Verstraeten, Aline, Loeys, Bart L.

    Published in Stem cell research (01-04-2023)
    “…Marfan syndrome (MFS) is a connective tissue disorder with pleiotropic manifestations in the ocular, skeletal and cardiovascular system. Ruptured aortic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    IPSC reprogramming of two patients with spondyloepiphyseal dysplasia congenita (SEDC) by De Kinderen, Pauline, Rabaut, Laura, Perik, Melanie H.A.M., Peeters, Silke, Ponsaerts, Peter, Loeys, Bart, Mortier, Geert, Meester, Josephina A.N., Verstraeten, Aline

    Published in Stem cell research (01-06-2023)
    “…Spondyloepiphyseal dysplasia congenita (SEDC) is a severe non-lethal type 2 collagenopathy caused by pathogenic variants in the COL2A1 gene, which encodes the…”
    Get full text
    Journal Article
  5. 5

    A generated induced pluripotent stem cell (iPSC) line (CMGANTi005-A) of a Marfan syndrome patient with an FBN1 c.7754T > C (p.Ile2585Thr) variation by Van Den Heuvel, Lotte J.F., Peeters, Silke, Meester, Josephina A.N., Perik, Melanie, Coucke, Paul, Loeys, Bart L.

    Published in Stem cell research (01-03-2023)
    “…Marfan syndrome (MFS) is a connective tissue disorder with pleiotropic manifestations in the ocular, skeletal and cardiovascular system; and is typically cause…”
    Get full text
    Journal Article
  6. 6

    IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type) by De Kinderen, Pauline, Peeters, Silke, Rabaut, Laura, Mortier, Geert, Ponsaerts, Peter, Loeys, Bart, Verstraeten, Aline, Meester, Josephina A.N.

    Published in Stem cell research (01-03-2023)
    “…Hemizygous missense variants in the X-linked BGN gene, encoding the extracellular matrix protein biglycan, cause spondyloepimetaphyseal dysplasia (SEMD,…”
    Get full text
    Journal Article
  7. 7

    The Genetics and Typical Traits of Thoracic Aortic Aneurysm and Dissection by Rodrigues Bento, Jotte, Meester, Josephina, Luyckx, Ilse, Peeters, Silke, Verstraeten, Aline, Loeys, Bart

    “…Genetic predisposition and risk factors such as hypertension and smoking can instigate the development of thoracic aortic aneurysm (TAA), which can lead to…”
    Get full text
    Journal Article
  8. 8

    Chondrodysplasias and Aneurysmal Thoracic Aortopathy: An Emerging Tale of Molecular Intersection by Verstraeten, Aline, Meester, Josephina, Peeters, Silke, Mortier, Geert, Loeys, Bart

    Published in Trends in molecular medicine (01-08-2020)
    “…Although at first glance chondrodysplasia and aneurysmal thoracic aortopathy seem oddly dissimilar, recent lines of evidences indicate that they share…”
    Get full text
    Journal Article
  9. 9

    Differentiation of Induced Pluripotent Stem Cells Into Chondrocytes: Methods and Applications for Disease Modeling and Drug Discovery by De Kinderen, Pauline, Meester, Josephina, Loeys, Bart, Peeters, Silke, Gouze, Elvire, Woods, Steven, Mortier, Geert, Verstraeten, Aline

    Published in Journal of bone and mineral research (01-03-2022)
    “…ABSTRACT Induced pluripotent stem cell (iPSC) technology allows pathomechanistic and therapeutic investigation of human heritable disorders affecting tissue…”
    Get full text
    Journal Article
  10. 10

    The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2 by Peeters, Silke, De Kinderen, Pauline, Meester, Josephina A. N., Verstraeten, Aline, Loeys, Bart L.

    Published in Human mutation (01-07-2022)
    “…Different pathogenic variants in the fibrillin‐1 gene (FBN1) cause Marfan syndrome and acromelic dysplasias. Whereas the musculoskeletal features of Marfan…”
    Get full text
    Journal Article
  11. 11

    An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome by Van Den Heuvel, Lotte J.F., Peeters, Silke, Meester, Josephina A.N., Coucke, Paul J., Loeys, Bart L.

    Published in Drug discovery today (01-07-2024)
    “…•No medical intervention can completely arrest aneurysmal growth.•Drugs with immediate translational potential in Marfan syndrome include resveratrol,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18